Exact Mass: 479.2209
Exact Mass Matches: 479.2209
Found 500 metabolites which its exact mass value is equals to given mass value 479.2209
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Nicardipine
A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents. [PubChem] CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3807; ORIGINAL_PRECURSOR_SCAN_NO 3803 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3813; ORIGINAL_PRECURSOR_SCAN_NO 3810 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7839; ORIGINAL_PRECURSOR_SCAN_NO 7837 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7818; ORIGINAL_PRECURSOR_SCAN_NO 7816 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7789; ORIGINAL_PRECURSOR_SCAN_NO 7787 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3822; ORIGINAL_PRECURSOR_SCAN_NO 3819 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3813; ORIGINAL_PRECURSOR_SCAN_NO 3811 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3884; ORIGINAL_PRECURSOR_SCAN_NO 3883 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3807; ORIGINAL_PRECURSOR_SCAN_NO 3805 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7827; ORIGINAL_PRECURSOR_SCAN_NO 7825 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7806; ORIGINAL_PRECURSOR_SCAN_NO 7805 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7845; ORIGINAL_PRECURSOR_SCAN_NO 7843 C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate
(S)-Methyl 2-(4-(((R)-2-amino-3-mercaptopropyl)amino)-2-(naphthalen-1-yl)benzamido)-4-methylpentanoate
N-[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]-L-alanyl-L-proline 3-nitrooxypropyl ester
Proxazole citrate
C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent
Phe Ala Asp Lys
nicardipine
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Ala Asp Phe Lys
Ala Asp Lys Phe
Ala Phe Asp Lys
Ala Phe Gly Trp
Ala Phe Lys Asp
Ala Phe Trp Gly
Ala Gly Phe Trp
Ala Gly Trp Phe
Ala Ile Asn Tyr
Ala Ile Tyr Asn
Ala Lys Asp Phe
Ala Lys Phe Asp
Ala Lys Met Met
Ala Leu Asn Tyr
Ala Leu Tyr Asn
Ala Met Lys Met
Ala Met Met Lys
Ala Asn Ile Tyr
Ala Asn Leu Tyr
Ala Asn Tyr Ile
Ala Asn Tyr Leu
Ala Gln Val Tyr
Ala Gln Tyr Val
Ala Val Gln Tyr
Ala Val Tyr Gln
Ala Trp Phe Gly
Ala Trp Gly Phe
Ala Tyr Ile Asn
Ala Tyr Leu Asn
Ala Tyr Asn Ile
Ala Tyr Asn Leu
Ala Tyr Gln Val
Ala Tyr Val Gln
Cys Glu Lys Thr
Cys Glu Thr Lys
Cys Lys Glu Thr
Cys Lys Met Val
Cys Lys Thr Glu
Cys Lys Val Met
Cys Met Lys Val
Cys Met Val Lys
Cys Arg Thr Thr
Cys Thr Glu Lys
Cys Thr Lys Glu
Cys Thr Arg Thr
Cys Thr Thr Arg
Cys Val Lys Met
Cys Val Met Lys
Asp Ala Phe Lys
Asp Ala Lys Phe
Asp Phe Ala Lys
Asp Phe Lys Ala
Asp Lys Ala Phe
Asp Lys Phe Ala
Asp Lys Met Ser
Asp Lys Ser Met
Asp Met Lys Ser
Asp Met Ser Lys
Asp Ser Lys Met
Asp Ser Met Lys
Glu Cys Lys Thr
Glu Cys Thr Lys
Glu Phe Gly Lys
Glu Phe Lys Gly
Glu Gly Phe Lys
Glu Gly Lys Phe
Glu Lys Cys Thr
Glu Lys Phe Gly
Glu Lys Gly Phe
Glu Lys Thr Cys
Glu Thr Cys Lys
Glu Thr Lys Cys
Phe Ala Gly Trp
Phe Ala Lys Asp
Phe Ala Trp Gly
Phe Asp Ala Lys
Phe Asp Lys Ala
Phe Glu Gly Lys
Phe Glu Lys Gly
Phe Gly Ala Trp
Phe Gly Glu Lys
Phe Gly Lys Glu
Phe Gly Trp Ala
Phe Ile Asn Ser
Phe Ile Ser Asn
Phe Lys Ala Asp
Phe Lys Asp Ala
Phe Lys Glu Gly
Phe Lys Gly Glu
Phe Leu Asn Ser
Phe Leu Ser Asn
Phe Asn Ile Ser
Phe Asn Leu Ser
Phe Asn Ser Ile
Phe Asn Ser Leu
Phe Asn Thr Val
Phe Asn Val Thr
Phe Gln Ser Val
Phe Gln Val Ser
Phe Ser Ile Asn
Phe Ser Leu Asn
Phe Ser Asn Ile
Phe Ser Asn Leu
Phe Ser Gln Val
Phe Ser Val Gln
Phe Thr Asn Val
Phe Thr Val Asn
Phe Val Asn Thr
Phe Val Gln Ser
Phe Val Ser Gln
Phe Val Thr Asn
Phe Trp Ala Gly
Phe Trp Gly Ala
Gly Ala Phe Trp
Gly Ala Trp Phe
Gly Glu Phe Lys
Gly Glu Lys Phe
Gly Phe Ala Trp
Gly Phe Glu Lys
Gly Phe Lys Glu
Gly Phe Trp Ala
Gly Ile Gln Tyr
Gly Ile Tyr Gln
Gly Lys Glu Phe
Gly Lys Phe Glu
Gly Leu Gln Tyr
Gly Leu Tyr Gln
Gly Gln Ile Tyr
Gly Gln Leu Tyr
Gly Gln Tyr Ile
Gly Gln Tyr Leu
Gly Trp Ala Phe
Gly Trp Phe Ala
Gly Tyr Ile Gln
Gly Tyr Leu Gln
Gly Tyr Gln Ile
Gly Tyr Gln Leu
Ile Ala Asn Tyr
Ile Ala Tyr Asn
Ile Phe Asn Ser
Ile Phe Ser Asn
Ile Gly Gln Tyr
Ile Gly Tyr Gln
Ile Asn Ala Tyr
Ile Asn Phe Ser
Ile Asn Ser Phe
Ile Asn Tyr Ala
Ile Gln Gly Tyr
Ile Gln Tyr Gly
Ile Ser Phe Asn
Ile Ser Asn Phe
Ile Tyr Ala Asn
Ile Tyr Gly Gln
Ile Tyr Asn Ala
Ile Tyr Gln Gly
Lys Ala Asp Phe
Lys Ala Phe Asp
Lys Ala Met Met
Lys Cys Glu Thr
Lys Cys Met Val
Lys Cys Thr Glu
Lys Cys Val Met
Lys Asp Ala Phe
Lys Asp Phe Ala
Lys Asp Met Ser
Lys Asp Ser Met
Lys Glu Cys Thr
Lys Glu Phe Gly
Lys Glu Gly Phe
Lys Glu Thr Cys
Lys Phe Ala Asp
Lys Phe Asp Ala
Lys Phe Glu Gly
Lys Phe Gly Glu
Lys Gly Glu Phe
Lys Gly Phe Glu
Lys Met Ala Met
Lys Met Cys Val
Lys Met Asp Ser
Lys Met Met Ala
Lys Met Ser Asp
Lys Met Val Cys
Lys Ser Asp Met
Lys Ser Met Asp
Lys Thr Cys Glu
Lys Thr Glu Cys
Lys Val Cys Met
Lys Val Met Cys
Leu Ala Asn Tyr
Leu Ala Tyr Asn
Leu Phe Asn Ser
Leu Phe Ser Asn
Leu Gly Gln Tyr
Leu Gly Tyr Gln
Leu Asn Ala Tyr
Leu Asn Phe Ser
Leu Asn Ser Phe
Leu Asn Tyr Ala
Leu Gln Gly Tyr
Leu Gln Tyr Gly
Leu Ser Phe Asn
Leu Ser Asn Phe
Leu Tyr Ala Asn
Leu Tyr Gly Gln
Leu Tyr Asn Ala
Leu Tyr Gln Gly
Met Ala Lys Met
Met Ala Met Lys
Met Cys Lys Val
Met Cys Val Lys
Met Asp Lys Ser
Met Asp Ser Lys
Met Lys Ala Met
Met Lys Cys Val
Met Lys Asp Ser
Met Lys Met Ala
Met Lys Ser Asp
Met Lys Val Cys
Met Met Ala Lys
Met Met Lys Ala
Met Gln Thr Thr
Met Arg Ser Ser
Met Ser Asp Lys
Met Ser Lys Asp
Met Ser Arg Ser
Met Ser Ser Arg
Met Thr Gln Thr
Met Thr Thr Gln
Met Val Cys Lys
Met Val Lys Cys
Asn Ala Ile Tyr
Asn Ala Leu Tyr
Asn Ala Tyr Ile
Asn Ala Tyr Leu
Asn Phe Ile Ser
Asn Phe Leu Ser
Asn Phe Ser Ile
Asn Phe Ser Leu
Asn Phe Thr Val
Asn Phe Val Thr
Asn Ile Ala Tyr
Asn Ile Phe Ser
Asn Ile Ser Phe
Asn Ile Tyr Ala
Asn Leu Ala Tyr
Asn Leu Phe Ser
Asn Leu Ser Phe
Asn Leu Tyr Ala
Asn Ser Phe Ile
Asn Ser Phe Leu
Asn Ser Ile Phe
Asn Ser Leu Phe
Asn Thr Phe Val
Asn Thr Val Phe
Asn Val Phe Thr
Asn Val Thr Phe
Asn Tyr Ala Ile
Asn Tyr Ala Leu
Asn Tyr Ile Ala
Asn Tyr Leu Ala
Gln Ala Val Tyr
Gln Ala Tyr Val
Gln Phe Ser Val
Gln Phe Val Ser
Gln Gly Ile Tyr
Gln Gly Leu Tyr
Gln Gly Tyr Ile
Gln Gly Tyr Leu
Gln Ile Gly Tyr
Gln Ile Tyr Gly
Gln Leu Gly Tyr
Gln Leu Tyr Gly
Gln Met Thr Thr
Gln Ser Phe Val
Gln Ser Val Phe
Gln Thr Met Thr
Gln Thr Thr Met
Gln Val Ala Tyr
Gln Val Phe Ser
Gln Val Ser Phe
Gln Val Tyr Ala
Gln Tyr Ala Val
Gln Tyr Gly Ile
Gln Tyr Gly Leu
Gln Tyr Ile Gly
Gln Tyr Leu Gly
Gln Tyr Val Ala
Arg Cys Thr Thr
Arg Met Ser Ser
Arg Ser Met Ser
Arg Ser Ser Met
Arg Thr Cys Thr
Arg Thr Thr Cys
Ser Asp Lys Met
Ser Asp Met Lys
Ser Phe Ile Asn
Ser Phe Leu Asn
Ser Phe Asn Ile
Ser Phe Asn Leu
Ser Phe Gln Val
Ser Phe Val Gln
Ser Ile Phe Asn
Ser Ile Asn Phe
Ser Lys Asp Met
Ser Lys Met Asp
Ser Leu Phe Asn
Ser Leu Asn Phe
Ser Met Asp Lys
Ser Met Lys Asp
Ser Met Arg Ser
Ser Met Ser Arg
Ser Asn Phe Ile
Ser Asn Phe Leu
Ser Asn Ile Phe
Ser Asn Leu Phe
Ser Gln Phe Val
Ser Gln Val Phe
Ser Arg Met Ser
Ser Arg Ser Met
Ser Ser Met Arg
Ser Ser Arg Met
Ser Val Phe Gln
Ser Val Gln Phe
Thr Cys Glu Lys
Thr Cys Lys Glu
Thr Cys Arg Thr
Thr Cys Thr Arg
Thr Glu Cys Lys
Thr Glu Lys Cys
Thr Phe Asn Val
Thr Phe Val Asn
Thr Lys Cys Glu
Thr Lys Glu Cys
Thr Met Gln Thr
Thr Met Thr Gln
Thr Asn Phe Val
Thr Asn Val Phe
Thr Gln Met Thr
Thr Gln Thr Met
Thr Arg Cys Thr
Thr Arg Thr Cys
Thr Thr Cys Arg
Thr Thr Met Gln
Thr Thr Gln Met
Thr Thr Arg Cys
Thr Val Phe Asn
Thr Val Asn Phe
Val Ala Gln Tyr
Val Ala Tyr Gln
Val Cys Lys Met
Val Cys Met Lys
Val Phe Asn Thr
Val Phe Gln Ser
Val Phe Ser Gln
Val Phe Thr Asn
Val Lys Cys Met
Val Lys Met Cys
Val Met Cys Lys
Val Met Lys Cys
Val Asn Phe Thr
Val Asn Thr Phe
Val Gln Ala Tyr
Val Gln Phe Ser
Val Gln Ser Phe
Val Gln Tyr Ala
Val Ser Phe Gln
Val Ser Gln Phe
Val Thr Phe Asn
Val Thr Asn Phe
Val Tyr Ala Gln
Trp Ala Phe Gly
Trp Ala Gly Phe
Trp Phe Ala Gly
Trp Phe Gly Ala
Trp Gly Ala Phe
Trp Gly Phe Ala
Tyr Gly Gln Ile
PROPIONIC ACID (1R,2S)-2-[N-BENZYL-N-(MESITYLENESULFONYL)AMINO]-1-PHENYLPROPYL ESTER
(1S,2R)-2-[N-Benzyl-N-(mesitylenesulfonyl)amino]-1-phenylpropyl Propionate
(S)-Methyl 2-(4-(((R)-2-amino-3-mercaptopropyl)amino)-2-(naphthalen-1-yl)benzamido)-4-methylpentanoate
2-[3-[(2,6-Dimethylphenoxy)methyl]-4-methoxyphenyl]-3-(3-pyridinylmethyl)-1,2-dihydroquinazolin-4-one
N,N-Diethyl-2-[4-[6-methoxy-2-(4-methoxyphenyl)-1H-inden-3-yl]phenoxy]ethanamine hydrochloride
(S)-Methyl 2-(4-(((R)-2-amino-3-mercaptopropyl)amino)-2-(naphthalen-1-yl)benzamido)-4-methylpentanoate
(2R)-2-amino-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[(1R,2R)-2-hydroxy-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]oxan-2-yl]sulfanylpropanoic acid
4-[[(4-methylphenyl)sulfonylamino]methyl]-N-[2-[(phenylmethyl)-propan-2-ylamino]ethyl]benzamide
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylbenzenesulfonamide
2-[(2R,4aS,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
2-[(2S,4aS,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylbenzenesulfonamide
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylbenzenesulfonamide
2-[(2R,4aR,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
N-[[(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2R,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
2-[(2S,4aS,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
2-[(2R,4aS,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
(2R,3R,3aS,9bS)-1-ethyl-7-(4-fluorophenyl)-3-(hydroxymethyl)-N-[2-(1-methyl-4-imidazolyl)ethyl]-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N-[[(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2R,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4R,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
2-[(2R,4aR,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
2-[(2S,4aR,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
2-[(2S,4aR,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
(2S,3S,3aR,9bR)-1-ethyl-7-(4-fluorophenyl)-3-(hydroxymethyl)-N-[2-(1-methyl-4-imidazolyl)ethyl]-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N,N-dimethyl-3-[4-[(1R,5S)-6-[[2-(trifluoromethyl)phenyl]methyl]-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzamide
3-O-[2-[benzyl(methyl)amino]ethyl] 5-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylate
1-Ethyl-4-(5-methylfuran-2-carbonyl)-1-(3-morpholin-4-ylpropyl)spiro[indole-3,5-pyrrolidine]-2,2,3-trione
2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylic acid O3-methyl ester O5-[2-[methyl-(phenylmethyl)amino]ethyl] ester
(8S)-cystein-S-yl-(7R,17S)-dihydroxy-(4Z,9,11,13Z,15E,19Z)-docosahexaenoic acid
A docosanoid that is (7R,17S)-dihydroxy-(4Z,9,11,13Z,15E,19Z)-docosahexaenoic acid in which a cysteinyl group is attached at position 8S via a sulfide linkage. An intermediate of specialised proresolving mediators.